A medical device having at least one invasive portion is disclosed. The medical device has a housing at least partially surrounding a tight chamber. The tight chamber sustains a pressure difference between an interior lumen of the tight chamber and the surrounding environment. The housing also has at least one deformable component. The housing is configured such that a state of deformation of the deformable component provides for a measurable indication of the pressure difference between the interior lumen of the tight chamber and the surrounding environment.
G01M 3/26 - Investigating fluid tightness of structures by using fluid or vacuum by measuring rate of loss or gain of fluid, e.g. by pressure-responsive devices, by flow detectors
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/1495 - Calibrating or testing in vivo probes
A method of operating a medical monitoring system includes providing stored program instructions for a software application. The software application is configured to be stored in a non-transitory memory of a computing device. Upon execution by a processor of the computing device, the software application is configured to (i) obtain measurement data, (ii) store image data of a nonmedical image on the non-transitory memory, (iii) modify the image data based on the measurement data to generate modified image data, and (iv) render the modified image data as a modified image on a display screen of the computing device. Modifying the image data includes changing a feature of the nonmedical image to represent the measurement data.
H04M 1/72427 - User interfaces specially adapted for cordless or mobile telephones with means for local support of applications that increase the functionality for supporting games or graphical animations
3.
INSERTION DEVICE AND METHOD FOR INSERTING A MEDICAL DEVICE
An insertion device (110) for inserting at least one insertable part of a medical device (112) into a body tissue (114) of a subject along an insertion axis (116) is disclosed. The insertion device (110) comprises an insertion tool (117), a cap (122), an insertion sleeve (124) and a guide sleeve (126) configured for guiding the insertion sleeve (124) therein, wherein the insertion sleeve (124) and/or the cap (122) in conjunction with the guide sleeve (126) form at least one friction pairing (128) comprising at least one elastic member (130) and at least one profile member (132), wherein at least one of the cap (122) and the insertion sleeve (124) comprises one of the at least one elastic member (130) and the at least one profile member (132) of the friction pairing (128) and wherein the guide sleeve (126) comprises the at least one other of the at least one elastic member (130) and the at least one profile member (132) of the friction pairing (128), wherein, for inserting the at least one insertable part of the medical device (112), the cap (122), the insertion tool (117) and the insertion sleeve (124) are configured to perform a movement (138) relative to the guide sleeve (126) from a distal position (134) to a proximal position (136) in a telescopic fashion, wherein the friction pairing (128), in response to an insertion force (140) acting on one or more of the cap (122) and the insertion sleeve (124) in a direction parallel to the insertion axis (116), is configured to provide a friction force changing with advancing of the movement (138) of one or more of the cap (122) and the insertion sleeve (124) from the distal position (134) to the proximal position (136), wherein in the distal position (136), the elastic member (130) and the profile member (132) of the at least one friction pairing (128) are spaced apart from each other, wherein one or both of the elastic member and the profile member comprises at least one material having a friction coefficient μ of 0.04 ≤ μ ≤ 0.12, specifically 0.06 ≤ μ ≤ 0.08. Further disclosed are an insertion system (111) and a method of inserting at least one insertable part of a medical device (112) into a body tissue (114) of a subject.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
A61B 17/00 - Surgical instruments, devices or methods
A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
The present invention relates to a computer-implemented method for determining a position of a wearable sensor patch (182) in a horizontal direction, wherein the wearable sensor patch (182) is positioned on a user's chest, wherein the wearable sensor patch (182) comprises at least one acceleration sensor (182) configured for generating acceleration sensor data, the method comprising: receiving the acceleration sensor data, wherein the acceleration sensor data is related to a walking movement of the user (196), wherein the acceleration sensor data comprises data related to the user walking in a forward or a backward direction during at least one left turn of the user and at least one right turn of the user, determining at least one left turn of the user (196) and at least one right turn of the user (196) while the user (196) is moving in a forward or a backward direction by evaluating the acceleration sensor data and, thereby, generating turn data, and determining a horizontal position of the wearable sensor patch (182) on the user's chest by evaluating the turn data, preferably wherein the horizontal position is determined relative to a horizontal center of the user's chest, wherein comparing the acceleration sensor data related to the at least one left turn and the acceleration sensor data related to the at least one right turn to each other is performed in order to determine an asymmetry in the turn data that is introduced due to a positioning of the wearable sensor patch in a horizontal direction that does not coincide with the horizontal center of the user's chest.
An insertion device for inserting at least an insertable part of a medical device into a body tissue of a subject is proposed, that includes: at least one housing with at least one holding structure adapted to releasably receive the medical device, at least one insertion tool configured for inserting at least the insertable part of the medical device, at least one wheel comprising a guiding structure configured for guiding an axial movement of the insertion tool and the holding structure between a distal position and a proximal position, and at least one torsional drive configured for rotating the wheel upon activation, wherein the guiding structure comprises a shape with an eccentricity relative to a center of the wheel and/or relative to a turning point of the wheel, wherein the eccentricity is unequal to zero, and wherein the shape is configured to slow a linear movement around a turning point of the insertion tool.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
6.
BODY MOUNT FOR MOUNTING AT LEAST ONE TRANSDERMAL MEDICAL DEVICE TO A BODY SURFACE OF A USER
A body mount for mounting at least one transdermal medical device to a body surface of a user is disclosed. The body mount includes: at least one base element having at least one mounting surface for attachment to the body surface of the user, at least one capillary for taking up blood from the body of the user when the base element is attached to the body surface of the user; and at least one bleeding detector configured for detecting blood in the capillary. Further disclosed are a medical device including the body mount, a medical kit including the medical device, a method of monitoring a transdermal medical device, and a method of determining at least one physiological parameter in a body tissue of a user and computer programs and computer-readable storage media for performing the methods.
Methods for predicting glucose values which involve determining a predicction time window using historical data indicative of glucose level influencing events of a person having diabetes and at least one predicted glucose level influencing event. Further disclosed are data processing systems for predicting glucose values, medical servers, user devices, and computer programs.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
A medical device for detecting at least one analyte in a body fluid, a method for assembling the medical device and a method of using the medical device are disclosed. The medical device comprises:
an analyte sensor having an insertable portion;
an insertion cannula receiving the insertable portion of the analyte sensor;
an electronics unit connected with the analyte sensor; and
a housing comprising an electronics compartment receiving the electronics unit and-a sensor compartment receiving the analyte sensor,
the sensor compartment forming a sealed compartment receiving the insertable portion of the analyte sensor,
the sealed compartment comprising detachable upper and lower caps,
the lower cap configured for detachment before insertion,
the insertion cannula being attached to the upper cap, wherein detaching the upper cap after insertion removes the insertion cannula,
wherein the electronics compartment at least partially surrounds the sensor compartment.
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A computer-implemented method and system for predicting and displaying glucose values, including receiving CGM data, determining, based on the data, a plurality of first predicted glucose values (33) for a first prediction time window (30), determining, based on the data, that a hypoglycemia event is predicted to occur during a second prediction time window (31) which has a contemporaneous beginning with the first prediction time window (30) but is shorter than the first window (30), and determining a plurality of second predicted glucose values (34) for the second prediction time window (31) and displaying the plurality of second predicted glucose values (34) for the second prediction time window (31) while not displaying predicted glucose values subsequent to the second prediction time window (31).
The present invention relates to a computer-implemented analytical measurement method for detecting a first analyte and a second analyte in a single sample of a bodily fluid, - wherein the first analyte is detectable from a first reagent test region (25) of a hybrid test element (40), the first reagent test region being configured for performing an optical detection reaction in the presence of the first analyte; - wherein the second analyte is detectable from a second reagent test region (26) of the hybrid test element, the second reagent test region being configured for performing an electrochemical detection reaction in the presence of the second analyte; and - wherein the first analyte is detectable from the first reagent test region, by using a camera (64) of a mobile device (60), when the hybrid test element is connected to an electrochemical reader unit (70); the method comprising: i) receiving an image captured by the camera of the mobile device, the image comprising a part of the first reagent test region having a first part of the single sample of the bodily fluid applied thereto; the image being captured when the hybrid test element is connected to an electrochemical reader unit; and ii) detecting the first analyte by using the image received in step i); and iii) detecting the second analyte by iii.a) using the image received in step i), the image further comprising a part of the electrochemical reader unit having an optically detectable indicator element (78) which is indicative of the electrochemical detection reaction; or iii.b) using a wireless signal received from the electrochemical reader unit (transmission unit 82), the wireless signal being indicative of the electrochemical detection reaction; wherein the second reagent test region has a second part of the single sample of the bodily fluid applied thereto.
G01N 33/52 - Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper
G01N 33/543 - ImmunoassayBiospecific binding assayMaterials therefor with an insoluble carrier for immobilising immunochemicals
G16H 30/00 - ICT specially adapted for the handling or processing of medical images
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
A continuous analyte monitor device includes a sensor and an electrical substrate. The sensor has (i) an in vivo portion including at least one electrode, and (ii) an ex vivo portion extending from the in vivo portion and including at least one electrical contact operably connected to the at least one electrode. The electrical substrate includes at least one base portion and at least one flexible portion extending from the at least one base portion. The at least one base portion is fixedly mounted relative to a housing of the continuous analyte monitor device. The at least one flexible portion includes a first contact pad. The at least one flexible portion is movable relative to the at least one base portion against the ex vivo portion, such that the electrical substrate biases the at least one flexible portion against a first side of the ex vivo portion.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
12.
SYSTEMS AND METHODS FOR COMORBIDITY DISEASE PROGRESSION MONITORING
Embodiments are described herein for automated tracking of disease progression with personalization for different cohorts or clusters of individuals and predictions of future progression with different treatment regimens. A dataset may be received related to individuals with a medical condition and a comorbidity. Training data may be extracted from the dataset for training a supervised learning model to classify individuals into a class of comorbidity progression. Correlations and/or the recommendations for treatment may be determined for different clusters or cohorts of individuals using an unsupervised learning model. Recommendations for treatment of the medical condition and/or the comorbidity may be based on the cluster or cohort with which an individual is associated.
G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
An insertion device for at least partially inserting a medical device into a body tissue of a subject is disclosed. The insertion system comprises: at least one medical device holding structure; an insertion component movable with the medical device holding structure from a distal position to a proximal position; at least one locking member having a predefined tensile strength Ftu, wherein the locking member is configured for holding the medical device holding structure and the insertion component in the distal position; and at least one pusher configured for applying an external force to overcome the predefined tensile strength of the locking member.
Embodiments are described herein for optimizing and personalizing therapeutic protocols to treat a medical condition. An event of a therapeutic protocol may be determined. One or more triggering events may be detected for generating a notification associated with the event of the therapeutic protocol. The one or more triggering events may be determined to exceed a notification threshold indicating a level of confidence that a user will receive a notification transmitted in response to the one or more triggering events. The notification may be provided to a user to assist in treatment of a medical condition, such as a diabetic condition, in response to the detected triggering event associated with the event of the therapeutic protocol.
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
15.
INSERTION SYSTEM AND METHOD FOR INSERTING A MEDICAL DEVICE
Insertion tool for inserting at least a part of a medical device into a subject, insertion device comprising the insertion tool and an insertion mechanism, and method for manufacturing the insertion tool, wherein the insertion tool comprises a penetrating portion that comprises a composite material comprising at least one first material and at least one second material. Wherein the first material is an amorphous material or amorphous composite and the second material is a fibrillary material or fibrillary composite or a crystalline material or crystalline composite. A fluid absorption of the first material of the composite material is higher than a fluid absorption of the second material of the composite material, and the insertion device is adapted to soften when in contact with a body fluid at least due to the fluid absorption of the amorphous material or amorphous composite.
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 17/00 - Surgical instruments, devices or methods
A61L 31/12 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material
A61L 31/14 - Materials characterised by their function or physical properties
A computer-implemented method of determining a numerical analyte result value corresponding to a concentration of an analyte in a sample of a bodily fluid of a subject applied to a reagent test region, that includes step (a) determining a numerical analyte result value based on an image of the reagent test region by using an algorithm which takes into account one or more parameters, each parameter being adapted to take more than one value, step (b) displaying the numerical analyte result value and/or a corresponding analyte value range and/or a corresponding message on a display device and step (c) automatically checking for available updated values for one or more of the parameters on a remote server before executing step (a), and, for each available updated value, updating the corresponding parameter value to be taken into account in step (a).
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
17.
BATTERY RELAXATION WITH NON-CONFORMING BLUETOOTH® COMMUNICATION BEHAVIOR
A computer implemented method for conserving power during BLUETOOTH® communication performed by a BLUETOOTH® enabled peripheral computing device, the method comprising advertising availability of the BLUETOOTH® enabled peripheral computing device for pairing, receiving a scan request from a BLUETOOTH® enabled central computing device. transmitting a scan response to the BLUETOOTH® enabled central computing device in response to the scan request, establishing a connection with the BLUETOOTH® enabled central computing device, monitoring a power consumption indicator of the peripheral computing device, introducing a delay period to a response period to a connection event received from the central computing device if the monitored power consumption indicator meets at least one predefined criteria, and wherein the delayed response period causes the response to occur after a predetermined peripheral latency period but prior to a supervision timeout.
G06F 1/3212 - Monitoring battery levels, e.g. power saving mode being initiated when battery voltage goes below a certain level
H04W 4/80 - Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication
H04W 48/16 - DiscoveringProcessing access restriction or access information
A method and system for establishing and executing a dynamic titration protocol for administration of an antidiabetic is disclosed. The method may include establishing an initial titration protocol and then applying an aggressiveness level to the initial titration protocol to obtain an initial use titration protocol. The initial use titration protocol may then be executed with a patient and glucose monitoring data may be received from the patient. The monitoring data may be used to perform a failsafe monitoring procedure and a revised aggressiveness level and titration protocol may be determined based on the results of the failsafe monitoring.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
19.
A SYSTEM AND METHOD FOR DYNAMIC TITRATION OF AN ANTIDIABETIC
A method and system for establishing and executing a dynamic titration protocol for administration of an antidiabetic is disclosed. The method may include establishing an initial titration protocol and then applying an aggressiveness level to the initial titration protocol to obtain an initial use titration protocol. The initial use titration protocol may then be executed with a patient and glucose monitoring data may be received from the patient. The monitoring data may be used to perform a failsafe monitoring procedure and a revised aggressiveness level and titration protocol may be determined based on the results of the failsafe monitoring.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
20.
Display screen with graphical user interface for glucose management
A method for operating a medical monitoring system includes obtaining continuous glucose monitoring ("CGM") data. The method generates predicted CGM data and obtains bedtime data indicating sleeping hours of the person. The method generates awake alert data when (i) the data indicates that the glucose concentration level is greater than an awake threshold for longer than a predetermined awake time period, (ii) the awake time period ends before the sleeping hours, and (iii) a predetermined waiting time period has elapsed since the awake or sleeping alert data was last generated. The method generates sleeping alert data when (i) the data indicates that the glucose concentration level is greater than a sleeping threshold for longer than a predetermined sleeping time period, (ii) the sleeping time period ends during the sleeping hours, and (iii) the waiting time period has elapsed since the sleeping or the awake alert data was last generated.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 20/70 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to mental therapies, e.g. psychological therapy or autogenous training
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
23.
METHODS AND SYSTEMS FOR PHOTOPLETHYSMOGRAPHIC DATA PREPARATION IN MACHINE-LEARNING TRAINING
A method for training a machine-learning (ML) model using photoplethysmographic (PPG) data has been developed. The method includes receiving PPG training data including series of PPG data corresponding to first and second optical wavelengths, generating time segments in the at least one PPG data set, selecting only a portion of the time segments having high-frequency noise beneath a predetermined threshold for inclusion in training data, removing a rolling average value for the from each time segment in the training data, identifying peaks and valleys in the training data, generating normalized amplitudes of the peaks and valleys in the training data, identifying waves in the normalized amplitudes, each wave being identified based on a spike in the normalized amplitudes, and generating a trained ML model to classify data relevant to a biomarker using a training process with an untrained ML model and the identified waves.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/1455 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using optical sensors, e.g. spectral photometrical oximeters
A continuous analyte monitor device includes a sensor, a first and second substrate, and at least one second electrical contact. The sensor includes (i) an in vivo portion having at least one electrode, and (ii) an ex vivo portion having at least one first electrical contact operably connected to the at least one electrode. The first substrate is configured to receive the sensor. The movable second substrate is configurable in (i) a first position in which a distal end of the second substrate is spaced apart from the first substrate, and (ii) a second position in which the distal end is against the first substrate and the sensor. The at least one second electrical contact is mounted on the first substrate or the distal end of the second substrate. In the second position the ex vivo portion is prevented from moving relative to the first substrate and the second substrate.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
25.
METHODS AND SYSTEMS FOR PHOTOPLETHYSMOGRAPHIC DATA PREPARATION IN MACHINE-LEARNING TRAINING
A method for training a machine-learning (ML) model using photoplethysmographic (PPG) data has been developed. The method includes receiving PPG training data including series of PPG data corresponding to first and second optical wavelengths, generating time segments in the at least one PPG data set, selecting only a portion of the time segments having high- frequency noise beneath a predetermined threshold for inclusion in training data, removing a rolling average value for the from each time segment in the training data, identifying peaks and valleys in the training data, generating normalized amplitudes of the peaks and valleys in the training data, identifying waves in the normalized amplitudes, each wave being identified based on a spike in the normalized amplitudes, and generating a trained ML model to classify data relevant to a biomarker using a training process with an untrained ML model and the identified waves.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/1455 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using optical sensors, e.g. spectral photometrical oximeters
26.
MEDICAL DEVICE FOR DETECTING AT LEAST ONE ANALYTE IN A BODY FLUID
A medical device for detecting an analyte in a body fluid has a base body for reversibly attaching the medical device to a patient's body and has an insertable analyte sensor with first and second electrodes. An electronics unit is connected to the sensor. The first and second electrodes each have a first free end and a second end, the second ends being electrically connected to respective electric conductors connecting the respective electrodes to the electronics unit. The first electrode extending from the second end and the second electrode extending from the second end are at least partially in electric contact with the body tissue of a patient during use of the medical device. The electrical resistance of the first electric conductor and the electrical resistance of the second electric conductor is higher than the electrical resistance of the first electrode and the electrical resistance of the second electrode.
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
This disclosure relates to a method, a mobile device, and a computer program, for managing medical data such as, e.g., glucose concentrations, by an electronic disease management system. In the method a change of the local time between generation of a first set of medical data and a second set of medical data is detected.
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
The present invention relates to to a computer-implemented method, a computer program, a non-transitory computer-readable storage medium, including instructions, a data processing device, and a health management device for predicting a potential effect and/or future concentration of an analyte in a bodily fluid as well as relates to a health management system for health management of a chronic disease. In order to improve health management, a subject is notified about an at least one upcoming future event and its potential effect on the analyte concentration in the bodily fluid of the subject.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
29.
METHOD AND SYSTEM FOR DETERMINING CONCENTRATION OF AN ANALYTE IN A SAMPLE OF A BODILY FLUID, AND METHOD AND SYSTEM FOR GENERATING A SOFTWARE-IMPLEMENTED MODULE
A method for generating a module configured to determine concentration of an analyte in a sample of a body fluid is disclosed. The method includes providing a first set of measurement data derived from images of one or more test strips indicating a color transformation in response to a body fluid containing an analyte. The images can be recorded by multiple devices with differing cameras, software and/or hardware device configurations for image recording and image data processing. A neural network model can be generated in a machine learning process applying an artificial neural network and a module configured to determine concentration of an analyte in a second sample of a body fluid can be generated. Further, the present disclosure includes a system for generating the module as well as a method and a system for determining concentration of an analyte in a sample of a bodily fluid.
The present invention relates to a computer-implemented analytical method for detecting at least one analyte in a bodily fluid, the method comprising: iii) selecting at least one algorithm from a set of algorithms; and iv) applying the at least one algorithm to at least a part of the measurement data retrieved in step i); wherein, in step iii), at least one predetermined default algorithm from the set of algorithms is selected, wherein, by applying the default algorithm to at least a part of the measurement data in step iv), at least one preliminary item of information describing one or both of the presence of the analyte in the bodily fluid and the concentration of the analyte in the bodily fluid is generated, wherein the preliminary item of information is subjected to at least one sufficiency test, wherein the at least one sufficiency test comprises at least one test selected from the group consisting of: - checking if the preliminary item of information contains a value within at least one predetermined range; - checking if the preliminary item of information fulfills at least one plausibility condition; - checking if the preliminary item of information contains accuracy information fulfilling at least one accuracy condition; - checking if the preliminary item of information indicates that at least one geometrical feature has been detected in the analytical measurement data; - checking if an obtained estimate value determined by using the selected at least one predetermined default algorithm from the set of algorithms is within a concentration range for which the predetermined default algorithm is optimized and/or selected.
G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
G01N 21/84 - Systems specially adapted for particular applications
31.
METHOD OF OPERATING A MEDICAL APPLICATION ON A MOBILE DEVICE HAVING AT LEAST ONE CAMERA
A method of operating a medical application on a mobile device (112) having at least one camera (114) and at least one display (116) is disclosed. The method comprises deriving at least one item of perceptivity information about a user's attention to at least one displayed critical screen and further comprises: a) receiving a predefined set of critical screens comprising critical content, wherein the critical content comprises information about one or more of, or wherein the critical content comprises a request for confirmation of one or more of: - applying of a sample of bodily fluid to at least one test field of an optical test element, - an occurred error, - injecting a bolus, - controlling an insulin pump, - delivering a medicament, - a user authentication; b) displaying to a user, on the display (116) of the mobile device (112), the at least one critical screen and deriving the at least one item of perceptivity information about the user's attention to the displayed critical screen by i) receiving at least one eye movement of the user from the camera (114), and ii) evaluating the user's eye movement, thereby deriving the item of perceptivity information; c) if the item of perceptivity information indicates that the user has perceived the critical content, prompting the user to confirm the critical content. Further, a mobile device (112) having at least one camera (114) and at least one display (116) and being configured for operating a medical application on the mobile device (112) is disclosed. Further disclosed are a kit (110), a computer program and a computer-readable storage medium.
G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G06F 3/01 - Input arrangements or combined input and output arrangements for interaction between user and computer
32.
METHOD OF DETECTING AN ANALYTE IN A SAMPLE OF BODILY FLUID
A method of detecting at least one analyte in a sample of bodily fluid by using a mobile device (112) having at least one camera (114) is disclosed. The method comprises: a) prompting a user to confirm an application of a sample of bodily fluid to at least one test field (118) of an optical test element (116), wherein the test field (118) of the optical test element (116) is configured for performing at least one optical detection reaction in the presence of the analyte in the sample of the bodily fluid, wherein the optical detection reaction is observable at least one predetermined position on the test field (118); b) receiving, from at least one sensor, at least one item of user response information about a user response, wherein the sensor is one or more of a sensor of the mobile device (112) and a sensor of a connected device connected to the mobile device (112), wherein the user response comprises one or more of - a gesture, and - an eye movement; c) deriving, from the item of user response information, at least one item of control information about the status of the application of the sample of bodily fluid; d) if the item of control information indicates that the sample of bodily fluid is applied to the test field (118) of the optical test element (116), receiving at least one image of at least a part of the test field (118) from the camera (114); and e) detecting the analyte by evaluating the at least one image. Further, a mobile device (112) having at least one camera (114) and being configured for detecting at least one analyte in a sample of bodily fluid is disclosed. Further disclosed are a kit (110), a computer program and a computer-readable storage medium.
An insertion device for inserting a medical device into a subject is disclosed. The insertion device has a chamber for receiving the medical device, an insertion tool for inserting an insertable portion of the medical device, an insertion mechanism, a retraction mechanism for retracting the insertion tool from the subject after insertion, a retaining mechanism for retaining the insertion tool in an end position after retraction, an inner housing having the retaining mechanism and the retracted insertion tool in the end position, an inserter housing having the insertion mechanism as well as a chamber for receiving the inner housing. The inserter housing is formed of recyclable or biodegradable or compostable material, the insertion device has an ejection mechanism to remove the inner housing from the chamber when the insertion tool is retrained within the inner housing by the retaining mechanism, and the ejection mechanism is activatable by the user.
This disclosure relates to a filling apparatus for filling a reusable reservoir of a medical dispensing device, the filling apparatus has a receiving portion for a reusable reservoir, a supply container for containing a liquid medication, a first connection port for fluidly connecting an inner volume of the reusable reservoir with the supply container, and a sterilization device that is configured for sterilizing the inner volume of the reusable reservoir. In order to provide an improved sterilization, the filling apparatus also includes a discharging device for discharging deposit from the inner volume of the reservoir. The sterilization device includes a radiation source for providing radiation for sterilizing the reusable reservoir. The reusable reservoir is housed in a radiation chamber.
A61M 5/14 - Infusion devices, e.g. infusing by gravityBlood infusionAccessories therefor
A61M 5/50 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests having means for preventing re-use, or for indicating if defective, used, tampered with or unsterile
35.
A METHOD FOR EVALUATING THE SUITABILITY OF AUTO-EXPOSURE SETTINGS OF A MOBILE DEVICE FOR PERFORMING A COLOR BASED MEASUREMENT
A method for evaluating the suitability of auto-exposure settings of a mobile device for performing a color based measurement, the mobile device having at least one camera for capturing an image representative of a scene is described.
H04N 23/71 - Circuitry for evaluating the brightness variation
H04N 23/73 - Circuitry for compensating brightness variation in the scene by influencing the exposure time
A61B 10/00 - Instruments for taking body samples for diagnostic purposesOther methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determinationThroat striking implements
A method, a mobile device and a kit for performing an analytical measurement are disclosed, wherein outliers are eliminated. In the inventive method, a mobile device having a camera and a test strip for performing a color-change detection reaction are provided. A sample is applied to a test field of the test strip and an image of at least part of the test strip is captured. A region of interest in the image is determined and associated with a first sub-set of pixels. A color distribution is evaluated and outliers are eliminated in the first sub-set of pixels. A sub-region of interest is determined within the region of interest and is associated with a second sub-set of pixels. Mean values of the color distributions of the first sub-set of pixels and the second sub-set of pixels are compared to thereby determine homogeneity information of the image.
G06T 7/90 - Determination of colour characteristics
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
G01N 21/84 - Systems specially adapted for particular applications
Disclosed is a method of continuously in vivo detecting an analyte in a bodily fluid over time, an analyte sensor system for in vivo continuously detecting an analyte in a bodily fluid over a measurement time span, and a computer program and a computer-readable storage medium. The method uses an analyte sensor with a working electrode that performs an electrochemical detection reaction with the analyte, and a further electrode having a redox material composition with silver and silver chloride. The method includes the following steps: monitoring a standard sensor signal derived by using the analyte sensor in a standard operation mode, comparing the standard sensor signal with a threshold to thereby determine if a change of the analyte sensor from the standard operation mode into an economy operation mode is required.
A61B 5/1468 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
38.
MEDICAL INFUSION DEVICE WITH A LEAKAGE DETERMINING MODULE
This disclosure relates to a medical infusion device having a reservoir for holding a liquid medicament, a cannula assembly, a fluid line, a drive mechanism, a dispensing member for dispensing medicament from reservoir through the fluid line and the cannula assembly, and a leakage determining module. For a more convenient determination of leakage of liquid medicament, the leakage determining module includes an electronic probe for receiving odor molecules and/or flavor molecules of the liquid medicament and the leakage determining module has evaluation electronics to determine presence of odor and/or flavor of the liquid medicament based on readings of the electronic probe.
A method for generating diabetes management parameter user interfaces includes providing stored program instructions of a first diabetes management application (DMA), the first DMA configured to be stored in a memory of an electronic device and, upon execution by a processor, the first DMA is configured to generate a first output display of a plurality of diabetes management parameters corresponding to a time series of analyte data, the plurality of diabetes management parameters depicting a trend of diabetes management parameter levels over time, generate a graphical indicator of a link to a second DMA stored in the memory, and activate the second DMA in response to an input selection of the link, wherein the second DMA is configured to be executed by the processor to generate a second output display of a current-time diabetes management parameter corresponding to the time series of the analyte data stored in the memory.
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
G16H 15/00 - ICT specially adapted for medical reports, e.g. generation or transmission thereof
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
40.
ELECTROCHEMICAL SENSING ELECTRODES AND BIOSENSORS AND PRODUCTION METHODS
Disclosed are methods for producing a sensing electrode in which an area of electrode material is applied to a substrate, a sensing chemistry material is applied to cover the electrode material, and a laser is used to form a laser cut the sensing chemistry material and the electrode material in a pattern to define at least a portion of the perimeter of the sensing electrode. The laser cut forms a gap physically and electrically separating the sensing chemistry material and the electrode material inside tire laser cut from the extraneous sensing chemistiy material and the electrode material outside the laser cut. The methods further provide for producing a plurality of sensing electrodes which are separated from a continuous substrate. Further disclosed are the sensing electrodes produced by such methods.
This disclosure teaches a computer-implemented method for providing a personalized healthcare parameter to a patient and a healthcare management system supporting a more reliable and error-free determination of a personalized healthcare parameter for the patient, such as a diabetes patient. The method involves providing a healthcare application and an interface application running in a data processing component having data processors.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
A method for determining a subject's analyte level is disclosed. The method comprises the steps of: • a) non-invasively detecting a first amount of at least one first volatile organic marker originating from a first source of the subject; • b) non-invasively detecting a second amount of at least the first volatile organic marker originating from a second source of the subject, wherein the second source is different from the first source; and • c) determining the subject's analyte level based on the first amount and on the second amount.
Management of a diabetic condition may be performed by detecting a mealtime and/or an increased level of activity associated with a user. The mealtime is detected based one or more mealtime indicators that may indicate a likelihood of an occurrence of a mealtime. Each mealtime indicator provides additional context around the likelihood of a mealtime. To assist in managing the diabetic condition, a user's elevated activity levels may be detected. The activity level of a user is detected based on one or more activity indicators. Each activity indicator provides additional context around the likelihood of an increased level of activity by the user. Management of the diabetic condition may be performed proximate a mealtime or a user exercising to increase the efficacy of management of the diabetic condition.
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
G06V 20/20 - ScenesScene-specific elements in augmented reality scenes
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
H04W 4/029 - Location-based management or tracking services
45.
METHOD OF DETERMINING A FINAL NUMERICAL ANALYTE RESULT VALUE CORRESPONDING TO A CONCENTRATION OF AN ANALYTE IN A BODILY FLUID USING A MOBILE DEVICE
A method of determining an analyte concentration in a body fluid using a mobile device with a camera is disclosed. A corresponding computer program, a non-transitory computer-readable storage medium, a corresponding mobile device, and a corresponding kit are also disclosed. In step a of the method, a numerical analyte result value from an image of a color formation of a reagent test region is determined. In step b, the numerical analyte result value and/or a corresponding analyte value range and/or a corresponding message is displayed. In step c), after step a) and before step b), an upper bias is added to the numerical analyte result value if it exceeds an upper threshold value, or a lower bias is subtracted if it falls below a lower threshold value, or it is kept unchanged it neither threshold value is passed.
An analyte sensor for use in medical devices for measuring analyte data in an analyte carrying fluid, in particular for measuring glucose data, which includes: a first electrode being a working electrode, a second electrode, a substrate carrying the first electrode and the second electrode, at least one membrane which at least partially covers the first electrode, wherein the at least one membrane comprises a membrane material that is impermeable to the analyte carrying fluid and/or the analyte, wherein the at least one membrane comprises at least one opening, and wherein the at least one membrane is configured for controlling the flux of the analyte carrying fluid and/or the analyte to the first electrode via the at least one opening. Methods of operation, a continuous analyte monitoring system and a kit with such a sensor are also disclosed.
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
47.
SYSTEM AND METHOD FOR ADAPTIVE GENERATION OF GRAPHICAL DATA OF PREDICTED DIAGNOSES
A method for generating a user interface of predicted disease progressions includes receiving medical data corresponding to patient visits to a healthcare provider, generating a diagnosis for the patient based on the medical data, and generating a predicted diagnosis for a future condition of the patient based upon the diagnosis, and a predictive model. The method further includes generating a timeline view of a diagnosis in the current patient visit and the predicted diagnosis. The graphical element of the diagnosis and the predicted diagnosis both include a graphical indicator of a diagnosis and at least one graphical sub-element of a physiological parameter relevant to the diagnosis. The method further includes generating a graphical connector between the graphical elements to indicate progression of time between a first time of the current patient visit and a second time.
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G06F 3/04847 - Interaction techniques to control parameter settings, e.g. interaction with sliders or dials
G06T 11/20 - Drawing from basic elements, e.g. lines or circles
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
48.
SYSTEM AND METHOD FOR ADAPTIVE GENERATION OF GRAPHICAL DATA OF A TREATMENT HISTORY
A method for generating graphical data of a patient treatment history includes receiving medical data for the patient corresponding to patient visits to a healthcare provider and generating graphical data corresponding to a timeline view of the patient visits. The generated graphical data include first and second graphical elements corresponding to first and second diagnoses based on the medical data during a current patient visit and a prior patient visit. Each graphical element includes a graphical indicator of a diagnosis for a medical condition and at least one graphical sub-element, the at least one graphical sub-element being relevant to a physiological parameter selected from the medical data and related to the diagnosis. The method includes generating a first graphical connector between the second graphical element and the first graphical element, to indicate a progression of time between patient visits in the timeline view.
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G06F 3/0482 - Interaction with lists of selectable items, e.g. menus
G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
An infusion delivery device has a reservoir for containing a liquid medicament, a dispensing member moveably arranged within the reservoir for dispensing liquid medicament out of the reservoir through an outlet of the reservoir, an actuation member for moving the dispensing member within the reservoir, and a controller for controlling the movement of the dispensing member within the reservoir by the actuation member. The controller determines an occlusion hindering the dispensing of liquid medicament out of the reservoir and provides a control signal to the actuation member upon determining the occlusion, to move the dispensing member in a reverse direction about a model-based displacement distance.
A method of evaluating the suitability of a mobile device for performing an analytical measurement based on a color formation reaction. The capability of the mobile device to have relevant settings of the mobile device controlled by software running on the mobile device is evaluated. The relevant settings pertain to image raw data processing steps to be carried out by the mobile device and may include a color space transformation and a tone mapping transformation. When the evaluation indicates that the mobile device is capable of having the relevant settings controlled by the software, control information indicating that the mobile device is suitable for performing the analytical measurement is provided. When the evaluation indicates that the mobile device is not capable of having the relevant settings controlled by the software, control information indicating that the mobile device is unsuitable for performing the analytical measurement is provided.
H04N 17/00 - Diagnosis, testing or measuring for television systems or their details
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1495 - Calibrating or testing in vivo probes
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
G01N 21/84 - Systems specially adapted for particular applications
G06T 7/80 - Analysis of captured images to determine intrinsic or extrinsic camera parameters, i.e. camera calibration
G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
H04N 23/62 - Control of parameters via user interfaces
51.
IDENTIFICATION METHOD AND ANALYTICAL METHOD OF DETECTING AT LEAST ONE ANALYTE IN A SAMPLE OF A BODILY FLUID
A computer-implemented identification method of identifying a user and a computer-implemented analytical method are disclosed. The identification method is configured for an analytical method of detecting at least one analyte in a sample of a bodily fluid. The identification method comprises using a mobile device (110), specifically a mobile communication device, the mobile device (110) having at least one camera (112) and at least one RFID reader device (114). The identification method comprises: a. prompting the user to identify by bringing at least one RFID identifier (116) of the user into a communication range of the RFID reader device (114); b. reading out data from the RFID identifier (116) by using the RFID reader device (114); c. validating the data read out in step b., wherein the validating comprises checking if at least one valid item of identification information of the user was successfully transferred with the data from the RFID identifier (116) to the RFID reader device (114). Further disclosed is a computer program and a computer-readable storage medium for performing any one of the methods.
G16H 10/65 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
52.
MEDICAL DEVICE ALERT, OPTIMIZATION, PERSONALIZATION, AND ESCALATION
An alert is used to inform a user that their blood glucose level has dropped below a threshold (e.g., the user is hypoglycemic) or has increased above a threshold (e.g., the user is hyperglycemic). There is a hierarchy of alerts from lowest priority to highest priority. The alert is communicated by a user device (e.g., a mobile device), which is, for example, a smartphone, smart watch, home automation device, or the like. The alert is modified in order to increase the likelihood that the user receives or acknowledges the alert within a minimal amount of time. An intensity level (e.g., a volume) of an alert is modified based on, for example, whether the user has acknowledged a previous alert. A modality or a sensory channel of an alert is changed if an initial alert does fails to elicit a response from the user.
G08B 3/10 - Audible signalling systemsAudible personal calling systems using electric transmissionAudible signalling systemsAudible personal calling systems using electromagnetic transmission
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/1171 - Identification of persons based on the shapes or appearances of their bodies or parts thereof
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G06V 40/16 - Human faces, e.g. facial parts, sketches or expressions
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
H03G 3/32 - Automatic control in amplifiers having semiconductor devices the control being dependent upon ambient noise level or sound level
A method for storing measurement data detected by a sensor and indicative of an analyte in a body fluid sample using a system having a processor and a memory. First and second measurement data indicative of first and second measurement values measured by a sensor, respectively, are provided. A relative measurement value is determined by the processor and is indicative of a value difference between the first and second measurement values. The first measurement value is stored in a first storage area having a first storage size in the memory. The relative measurement value is stored in a second storage area having a second storage size in the memory that is smaller than the first storage size. An indicator is also stored in the memory and is assigned to the relative measurement storage data in the memory and is indicative of a characteristic of the relative measurement storage data.
A method of titrating an antidiabetic for a patient is disclosed, along with a system for performing the method. The method includes providing a database having anonymized personal parameters for a plurality of previously managed subjects and generating cohorts from the plurality of previously managed subjects based on similarities in the anonymized personal parameters. The method further includes receiving patient specific personal parameters and identifying from the generated cohorts a patient similar cohort corresponding to the patient specific personal parameters. A titration output parameter to optimize may either be entered or computed. Based on the titration output parameter to optimize and the patient similar cohort, a customized titration protocol for the patient can then be derived.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G16H 20/00 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
G16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
A method of individualizing analyte value ranges used to categorize a concentration of an analyte in a sample of a bodily fluid of a subject applied to a reagent test region and determined using a mobile device having a processing device, as well as a corresponding computer program, a non-transitory computer-readable storage medium with corresponding instructions, a corresponding mobile device, and a corresponding kit. The method comprises the steps of determining a numerical analyte result value from an image of a color formation of the reagent test region, attributing the numerical analyte result value to a corresponding analyte value range, and adapting one or more range limit values based on a plurality of numerical analyte result values previously determined for different samples of the subject's bodily fluid taken at different points in time.
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
G01N 21/77 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
A method of titrating an antidiabetic for a patient is disclosed, along with a system for performing the method. The method includes providing a database having anonymized personal parameters for a plurality of previously managed subjects and generating cohorts from the plurality of previously managed subjects based on similarities in the anonymized personal parameters. The method further includes receiving patient specific personal parameters and identifying from the generated cohorts a patient similar cohort corresponding to the patient specific personal parameters. A titration output parameter to optimize may either be entered or computed. Based on the titration output parameter to optimize and the patient similar cohort, a customized titration protocol for the patient can then be derived.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
An insertion system comprising at least one screw coupling configured for coupling at least one first element and at least one second element of the insertion system is disclosed. The screw coupling is configured such that the first element and the second element are assembled without rotational movement. The screw coupling comprises at least one radially flexible part configured for radial movement and/or deformation when assembling the first element and the second element, wherein the radially flexible part is a part of the first element or second element; and elastic means configured for applying a force in an axial direction to the screw coupling, wherein the elastic means is pre-loadable in the axial direction during assembly of the insertion system.
A connector (20) for securing a sensor (32) to a circuit member (34). The connector includes a first member (22) have at least one first engagement surface (26) and a second member (24) having at least one second engagement surface (28). The first engagement surface engages the second engagement surface when the first member and the second member are secured together. A biasing member (30) is coupled with one of the first and second members and exerts a biasing force forcing the first engagement surface into contact with the second engagement surface and is also adapted to bias the sensor (32) into engagement with the circuit member (34). The engagement of the first and second engagement surfaces may conductively couple the first and second members whereby the sensor may be conductively coupled with the circuit member via the connector. A method of assembling a sensor assembly using the connector is also disclosed.
A method for medication bolus calculation has been developed. The method includes receiving physiological measurements from an analyte sensor coupled to a user, receiving data corresponding to at least one meal event including a timestamp corresponding to when a meal was consumed, identifying a missed meal event time corresponding to a meal consumed by the user but not to the timestamp of any meal event, the recommended bolus being calculated based, at least in part, upon an length of time elapsed from the missed meal event time to a current time, and generating an output message indicating the recommended bolus of the medication.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
60.
INSERTION DEVICE, INSERTION SYSTEM AND METHOD FOR INSERTING A MEDICAL DEVICE
An insertion device has a guide sleeve at its proximal end that contacts the skin for an insertion process. A cap at the distal end of the device can be pressed to carry out the insertion process while moving in the direction of the proximal end. An inserter sleeve is at least partially within the guide sleeve and/or the cap and has a holder for the medical device, and the inserter sleeve is moveable with respect to the guide sleeve. A retractor is moveable along a movement path and retracts a portion provided with the medical device. An elastic element biases the retractor towards the distal end along the movement path. A retractor control controls the movement of the retractor by blocking or freeing the movement of the retractor along the movement path, and the retractor control is rotatable with respect to the retractor.
A method of determining a color expectation range for assessing the plausibility of an assumed reaction time value used in an analytical measurement based on a color formation reaction and a measurement method of performing an analytical measurement based on a color formation reaction by using a mobile device having a camera and a processor are disclosed. Further disclosed are a determination system for determining a color expectation range for assessing the plausibility of an assumed reaction time value used in an analytical measurement based on a color formation reaction, a mobile device having a camera and a processor, a kit for determining the concentration of at least one analyte in a sample of a body fluid having the mobile device as well as computer programs and computer-readable storage media having instructions which, when performed on the respective device, cause the device to perform the determination method and/or the measurement method.
G01N 33/50 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
G06T 7/90 - Determination of colour characteristics
A battery clip (110) for retaining at least one battery (162) to at least one battery contact pad (152) of a circuit carrier (150) is disclosed. The battery clip (110) comprises at least one housing (112). The housing (112) comprises at least one receptacle (114) for at least partially receiving the circuit carrier (150) and the battery (162). The receptacle (114) comprises at least one opening (116) through which the battery (162) and the circuit carrier (150) are at least partially insertable. The housing (112) comprises or is at least partially formed by at least one first contact spring element (166) and by at least one second contact spring element (118). The first contact spring element (166) and the second contact spring element (118) are configured for retaining the battery (162) to the battery contact pad (152) of the circuit carrier (150). The first contact spring element (166) is configured for contacting the battery (162) being arranged on a first side (168) of the circuit carrier (150) being inserted into the receptacle (114). The second contact spring element (118) is configured for contacting a second side (170) of the circuit carrier (150) being inserted into the receptacle (114), the second side (170) opposing the first side (168).
H01M 50/216 - Racks, modules or packs for multiple batteries or multiple cells characterised by their shape adapted for button or coin cells
H01M 50/244 - Secondary casingsRacksSuspension devicesCarrying devicesHolders characterised by their mounting method
H01M 50/247 - MountingsSecondary casings or framesRacks, modules or packsSuspension devicesShock absorbersTransport or carrying devicesHolders specially adapted for portable devices, e.g. mobile phones, computers, hand tools or pacemakers
H01M 10/42 - Methods or arrangements for servicing or maintenance of secondary cells or secondary half-cells
A battery clip for retaining at least one battery to a circuit carrier is disclosed along with an assembly including a circuit carrier having a plurality of flexible tabs and a battery clip configured to be secured to the circuit carrier to securely retain a battery thereto for providing power to the circuit carrier. The battery clip includes a plurality of slots configured to mate with and receive the flexible tabs of the circuit carrier such that the battery clip and the circuit carrier are secured together such that a first terminal of a retained battery physically contacts and is in electrical communication with the circuit carrier's first pad, the battery clip further comprising one or more flexible conductive fingers configured to contact a second terminal of a retained battery to establish an electrical communication between the fingers and the second terminal, and wherein the battery clip comprises an electrically conductive material and establishes electrical communication between the fingers and the circuit carrier's second pad.
Methods and devices for determining the concentration of at least one analyte in a bodily fluid. Including a determination method of determining a color expectation range for assessing the plausibility of a color formation value obtained in an analytical measurement based on a color formation reaction and a measurement method of performing an analytical measurement based on a color formation reaction by using a mobile device having a camera and a processor. Further including a determination system for determining a color expectation range for assessing the plausibility of a color formation value obtained in an analytical measurement based on a color formation reaction. The determination system comprises a training set of optical test strips having a reagent test region. At least two of the training optical test strips are non-corrupted and at least two are corrupted.
G01N 33/66 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving blood sugars, e.g. galactose
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
Analyte sensor for use in medical devices for measuring analyte data such as glucose data, including: a power source providing electrical power to the analyte sensor, an enclosure of the analyte sensor, a sensor circuit powered by the power source and including two electrodes, wherein the electrodes each have a first portion that lies inside the enclosure and a second portion that lies outside of the enclosure. At least one protection unit is electrically coupled to the first portion of each of the two electrodes located inside the enclosure, wherein the at least one protection unit is configured to short-circuit the two electrodes in case a voltage signal from the sensor circuit applied to the electrodes exceeds a predetermined voltage threshold. A method for operating an analyte sensor is also disclosed.
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
66.
DMS - INTERACTIVE PRODUCT IDENTIFICATION FOR A CALL CENTER
This disclosure lies in the field of a computer implemented method of routing a video call from a call center computer system comprising a controller, a transceiver, and a machine learning system, to a product service agent computer system assigned to a certain medical device product type and associated services. This disclosure involves using artificial intelligence in order to identify a medical device product based on recorded product image data. Further aspects of this disclosure provide a corresponding call center computer system for routing a video call initiated by a mobile device from the call center computer system to a medical device product service agent computer system as well as a computer-implemented method for generating a model of a medical device product type.
G08B 13/196 - Actuation by interference with heat, light, or radiation of shorter wavelengthActuation by intruding sources of heat, light, or radiation of shorter wavelength using passive radiation detection systems using image scanning and comparing systems using television cameras
H04N 7/18 - Closed-circuit television [CCTV] systems, i.e. systems in which the video signal is not broadcast
H04N 23/661 - Transmitting camera control signals through networks, e.g. control via the Internet
67.
MEDICAL DEVICE COMPRISING A TEMPERATURE SENSITIVE ACTIVATION LABEL
A medical device comprising a medical tool and an activation label connected to the medical tool, wherein the activation label comprises an activation code required for activating the medical device, the medical device comprising a controller connected to the medical tool, which is configured to receive an activation signal from a remote control device, and wherein the activation label comprises a temperature sensitive part that is configured to change its appearance at a predetermined temperature condition, in particular such that it masks at least part of the activation code if the predetermined temperature condition is reached.
G16H 40/60 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G09F 3/00 - Labels, tag tickets, or similar identification or indication meansSealsPostage or like stamps
68.
BODY-WEARABLE MEDICAL DEVICE WITH A SEALING ELEMENT
A body-wearable medical device has first and second housing portions. The first housing portion has a female portion and the second housing portion has a male portion. The male portion is at least partially inserted into the female portion, thereby defining a circumferential clearance gap. A circumferential sealing element is arranged in the circumferential clearance gap between the female portion and the male portion. In order to provide a body-wearable medical device with improved sealing that is less prone to failure by stress and forces exerted on the body-wearable medical device, the female portion and the male portion are fixed to each other by a circumferential fixation glue arranged in the circumferential clearance gap between the female portion and the male portion next to the circumferential sealing element.
A61B 50/30 - Containers specially adapted for packaging, protecting, dispensing, collecting or disposing of surgical or diagnostic appliances or instruments
A61B 50/00 - Containers, covers, furniture or holders specially adapted for surgical or diagnostic appliances or instruments, e.g. sterile covers
69.
METHODS AND DEVICES FOR PERFORMING AN ANALYTICAL MEASUREMENT
A determination method of determining a dynamic coefficient of variation limit (CvTR, lim) for assessing validity of an optical test strip usable for an analytical measurement based on a color formation reaction is disclosed. Training sets of optical test strips and mobile devices are provided. A color reference card is also provided. Images are captured of reagent test regions of the optical test strip and of a color reference field(s) of the reference card. A training set of pairs of reagent test region coefficients of variation (CvTR) and corresponding minimum color reference field coefficients of variation (CvRF, min) are determined. A relation for determining the dynamic coefficient of variation limit (CvTR, lim) for the respective reagent test region is derived. The dynamic coefficient of variation limit (CvTR, lim) defines a maximum coefficient of variation (CvTR, max) for reagent test regions of non-corrupted optical test strips.
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
G01N 21/77 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
G06T 7/90 - Determination of colour characteristics
70.
CUSTOMIZABLE CONTINUOUSLY UPDATED EVENT MONITORING FOR SCREENS ON COMPUTING DEVICE
A computing device may provide access to information related to the medical condition or health of the user in the form of an overlay notification when the computing device is displaying a graphical user interface. The overlay notification may be dynamically and/or continuously updated on the graphical user interface of the device in response to updated data. The overlay notification may be enabled/disabled in response to overlay notification triggering events/overlay notification removal events. When multiple types of information are to be displayed at a time, the computing device may group the information into a common overlay notification that may be updated dynamically and/or continuously in response to updated data. As the information that is provided in the overlay notification may be sensitive information, the information in the overlay notification may be prevented from being displayed until additional input is received from the user.
G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G06F 3/0481 - Interaction techniques based on graphical user interfaces [GUI] based on specific properties of the displayed interaction object or a metaphor-based environment, e.g. interaction with desktop elements like windows or icons, or assisted by a cursor's changing behaviour or appearance
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
71.
CUSTOMIZABLE CONTINUOUSLY UPDATED EVENT MONITORING FOR SCREENS ON COMPUTING DEVICE
A computing device may provide access to information related to the medical condition or health of the user in the form of an overlay notification when the computing device is displaying a graphical user interface. The overlay notification may be dynamically and/or continuously updated on the graphical user interface of the device in response to updated data. The overlay notification may be enabled/disabled in response to overlay notification triggering events/overlay notification removal events. When multiple types of information are to be displayed at a time, the computing device may group the information into a common overlay notification that may be updated dynamically and/or continuously in response to updated data. As the information that is provided in the overlay notification may be sensitive information, the information in the overlay notification may be prevented from being displayed until additional input is received from the user.
G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G06F 3/0481 - Interaction techniques based on graphical user interfaces [GUI] based on specific properties of the displayed interaction object or a metaphor-based environment, e.g. interaction with desktop elements like windows or icons, or assisted by a cursor's changing behaviour or appearance
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
72.
BODY-WEARABLE MEDICAL DEVICE COMPRISING A SUPERABSORBENT SUBSTANCE
A body-wearable medical device has a medical device housing having a transcutaneous element configured for being at least partially inserted into a patient's body at an insertion site during use of the body-wearable medical device. A base is configured for reversibly attaching the body-wearable medical device during its use to a patient's skin. The base has a first side that faces the patient's body and that also has an adhesive for adhering the body-wearable medical device to a patient's skin. For reducing a likelihood of contamination by body fluid flowing out of the insertion lesion, the base on its first side also has a superabsorbent substance and at least one fluid channel. The fluid channel is configured to guide body fluid from the insertion site to the superabsorbent substance.
A61F 13/53 - Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the bodySupporting or fastening means thereforTampon applicators characterised by the absorbing medium
A61F 13/531 - Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the bodySupporting or fastening means thereforTampon applicators characterised by the absorbing medium having a homogeneous composition through the thickness of the pad
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
73.
INSERTION TOOL FOR INSERTING AT LEAST ONE MEDICAL DEVICE INTO A BODY TISSUE
An insertion tool (114) for inserting at least one insertable part of a medical device into a body tissue of a subject is proposed. The insertion tool (114) comprises a shaft (116) configured for receiving the medical device. The shaft (116) comprises an insertable first end (118) and an adjustable second end (120).
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests
An electronic circuit configured to operate an analyte sensor, such as a glucose sensor, the circuit having at least a first and a second electrical connection configured to be connected to a first and a second electrode of the analyte sensor respectively. The electronic circuit has a voltage source and a common potential conductor section electrically provided on a potential of a pole of the voltage source, wherein, with the voltage source, an electric potential different from the potential of the common potential conductor section can be provided to the first electrical connection, and wherein the second electrical connection is connected to the common potential conductor section through one or more common potential connection paths wherein none of the common potential connection paths connects the second electrical connection to the common potential conductor section through fewer than three or more series-connected electronic components.
An inventive medical system has a housing with a first guiding surface. A preassembled module is received in the housing. The module includes electronics electrically connected to an analytical sensor, an insertion component configured for inserting the analytical sensor into body tissue of a user and a sterility cap at least partially surrounding the insertion component. The module has a second guiding surface. A protective cap is removably connected to the housing and covers the preassembled module. The protective cap is removable from the housing by pulling the protective cap from the housing. The first guiding surface guides the protective cap during the pulling of the protective cap from the housing and the second guiding surface guides the sterility cap during pulling the sterility cap from the insertion component. The length of the first guiding surface exceeds the length of the second guiding surface.
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
76.
BODY WEARABLE ANALYTE SENSOR SYSTEM WITH INFRARED TEMPERATURE SENSOR DEVICE
An analyte sensor system has a transcutaneous analyte sensor. A housing is provided that has a lower side configured to be attached to the skin of a patient. An infrared (IR) temperature sensor detects the temperature (i) of the lower side of the housing or (ii) of the skin through a hole in the lower side of the housing. The IR temperature sensor faces and is spaced from the lower side of the housing or is spaced from the skin. An electronics unit has a processor that receives analyte sensor signals from the transcutaneous analyte sensor and temperature sensor signals from the IR temperature sensor device. The analyte sensor system may also include a contact temperature sensor in contact with a part of the housing carrying the IR temperature sensor or in contact with the circuit board.
A medical device (112) having at least one invasive portion (124) is disclosed. The medical device (112) comprises at least one housing (114) at least partially surrounding at least one tight chamber (116). The tight chamber (116) is configured for sustaining a pressure difference between at least one interior lumen (118) of the tight chamber (116) and a surrounding environment (120). The housing (114) comprises at least one deformable component (122). The housing (114) is configured such that a state of deformation of the deformable component (122) provides for a measurable indication of the pressure difference between the interior lumen (118) of the tight chamber (116) and the surrounding environment (120).
A method of operating a medical monitoring system includes providing stored program instructions for a software application. The software application is configured to be stored in a non-transitory memory of a computing device. Upon execution by a processor of the computing device, the software application is configured to (i) obtain measurement data, (ii) store image data of a nonmedical image on the non-transitory memory, (iii) modify the image data based on the measurement data to generate modified image data, and (iv) render the modified image data as a modified image on a display screen of the computing device. Modifying the image data includes changing a feature of the nonmedical image to represent the measurement data.
G16H 20/00 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
79.
SYSTEM AND METHOD FOR DISPLAYING AN IMAGE-BASED REPRESENTATION OF MEASUREMENT DATA
A method of operating a medical monitoring system includes providing stored program instructions for a software application. The software application is configured to be stored in a non-transitory memory of a computing device. Upon execution by a processor of the computing device, the software application is configured to (i) obtain measurement data, (ii) store image data of a nonmedical image on the non-transitory memory, (iii) modify the image data based on the measurement data to generate modified image data, and (iv) render the modified image data as a modified image on a display screen of the computing device. Modifying the image data includes changing a feature of the nonmedical image to represent the measurement data.
G16H 20/00 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
An insertion device (112) for inserting at least an insertable part of a medical device (110) into a body tissue (114) of a subject is proposed, comprising: - at least one housing (116) with at least one holding structure (118) adapted to releasably receive the medical device (110), - at least one insertion tool (120) configured for inserting at least the insertable part of the medical device, - at least one wheel (132) comprising a guiding structure (134) configured for guiding an axial movement of the insertion tool (120) and the holding structure (118) between a distal position and a proximal position, and - at least one torsional drive (146) configured for rotating the wheel (132) upon activation, wherein the guiding structure (134) comprises a shape with an eccentricity relative to a center of the wheel (132) and/or relative to a turning point of the wheel (132), wherein the eccentricity is unequal to zero, and wherein the shape is configured to slow a linear movement around a turning point of the insertion tool (120).
Systems, devices and methods for assisting users in locating sources of carb-related food items. A hypoglycemic event is detected via a blood glucose monitoring device and a location of a user's mobile device is detected during the hypoglycemic event. In response to the location of the mobile device being at the user's home, carb-related food items in a refrigerator or carb-related food items purchased within a predefined period of time are displayed on the mobile device. In response to the location of the mobile device being outside of the user's home, locations of a predefined source of carbohydrates outside of the home are displayed on the mobile device.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
Medical devices and methods are disclosed for detecting an analyte in a body fluid. The medical device comprises an analyte sensor having an insertable portion adapted for insertion into body tissue of a user. An insertion cannula receives the analyte sensor therein. A housing forms a sealed sensor compartment receiving an insertable portion of the analyte sensor. The sealed sensor compartment comprises a detachable upper cap and a detachable lower cap. The detachable lower cap is configured for detachment before sensor insertion. The cannula is attached to the detachable upper cap, wherein the detachable upper cap is configured for detachment after insertion, thereby removing the insertion cannula. The analyte sensor is operably connected to an electronics unit comprising an interconnect device with at least one electronic component attached thereto
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
B08B 5/00 - Cleaning by methods involving the use of air flow or gas flow
B08B 7/00 - Cleaning by methods not provided for in a single other subclass or a single group in this subclass
83.
ANALYTE SENSOR AND METHOD FOR MANUFACTURING AN ANALYTE SENSOR
The disclosure relates to an analyte sensor comprising a substrate, at least one working electrode, at least one second electrode and a membrane, wherein the membrane is located on top of the second electrode, and the second electrode has at least one first silver layer and at least one second silver layer which partially overlap with one another and have the same composition. The first and second silver layers intersect with one another to form a + or a T shape design. The sensor includes at least one exposed area of the first silver layer disposed on the exterior of the sensor to provide for direct contact with body fluid when implanted. The disclosure further relates to a process for manufacturing an analyte sensor.
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
84.
COMPUTER-IMPLEMENTED METHODS FOR PREDICTING GLUCOSE VALUES, DATA PROCESSING SYSTEM, AND APP
A computer-implemented method and system for predicting and displaying glucose values, including receiving CGM data, determining, based on the data, a plurality of first predicted glucose values (33) for a first prediction time window (30), determining, based on the data, that a hypoglycemia event is predicted to occur during a second prediction time window (31) which has a contemporaneous beginning with the first prediction time window (30) but is shorter than the first window (30), and determining a plurality of second predicted glucose values (34) for the second prediction time window (31) and displaying the plurality of second predicted glucose values (34) for the second prediction time window (31 ) while not displaying predicted glucose values subsequent to the second prediction time window (31).
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G16H 40/60 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
G16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
85.
DETECTION REAGENTS AND ELECTRODE ARRANGEMENTS FOR MULTI-ANALYTE DIAGNOSTIC TEST ELEMENTS, AS WELL AS METHODS OF USING THE SAME
Detection reagents, multi-analyte test elements, test systems, and multi-analyte measuring methods are provided. In particular, multi-analyte test elements have (1) a first working electrode and first counter electrode pair covered with a first analyte-specific reagent that includes an enzyme, a coenzyme and a first mediator and have (2) a second working electrode covered with a second analyte-specific reagent that includes an enzyme, a coenzyme and a second mediator, where the second mediator is different than the first mediator. The single counter electrode can be used as the counter electrode for both the first and second analyte measurements at their respective working electrodes. Moreover, the mediator concentrations, measurement ranges, and applied potential differences are not the same for each analyte-specific measurement.
C12Q 1/00 - Measuring or testing processes involving enzymes, nucleic acids or microorganismsCompositions thereforProcesses of preparing such compositions
A body mount (126) for mounting at least one transdermal medical device (128) to a body surface (130) of a user (132) is disclosed. The body mount (126) comprises: - at least one base element (134) having at least one mounting surface (136) for attachment to the body surface (130) of the user (132), - at least one capillary (138) for taking up blood from the body of the user (132) when the base element (134) is attached to the body surface (130) of the user (132); - at least one bleeding detector (150) configured for detecting blood in the capillary (138). Further disclosed are a medical device (124) comprising the body mount (126), a medical kit (164) comprising the medical device (124), a method of monitoring a transdermal medical device (128), and a method of determining at least one physiological parameter in a body tissue of a user (132) and computer programs and computer-readable storage media for performing the methods.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/1455 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using optical sensors, e.g. spectral photometrical oximeters
A61B 5/1459 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/1495 - Calibrating or testing in vivo probes
The present disclosure refers to computer-implemented methods for predicting glucose values. Further, the present disclosure refers to a data processing system for predicting glucose values, a medical server, a user device, and a computer program.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G16H 40/60 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
G16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A computer-implemented method of operating a cloud server (114) for providing blacklist information, the method comprising: i. providing a cloud-based blacklist database (124) on the cloud server (114), the blacklist database comprising blacklist information on a plurality of mobile devices (112), each mobile device (112) having at least one camera (116), the blacklist information comprising information on the suitability of at least one of the mobile devices (112)' hardware and the mobile devices (112)' software for performing at least one analytical measurement; ii. providing, upon request by a requesting mobile device (112) of the plurality of mobile devices (112), at least one item of blacklist information from the blacklist database to the requesting mobile device (112), the blacklist information comprising information on the suitability of at least one of the requesting mobile device's hardware and the requesting mobile device's software for performing the at least one analytical measurement; iii. receiving at least one item of individual check result information from a sending mobile device (112) of the plurality of mobile devices (112), the item of check result information comprising information on the suitability of at least one of the sending mobile device's hardware and the sending mobile device's software for performing the at least one analytical measurement; iv. evaluating the item of individual check result information for the necessity of updating the blacklist information on the blacklist database.
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G01N 21/00 - Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
90.
OPTIMIZATION AND PERSONALIZATION OF THERAPEUTIC PROTOCOLS
Embodiments are described herein for optimizing and personalizing therapeutic protocols to treat a medical condition. An event of a therapeutic protocol may be determined. One or more triggering events may be detected for generating a notification associated with the event of the therapeutic protocol. The one or more triggering events may be determined to exceed a notification threshold indicating a level of confidence that a user will receive a notification transmitted in response to the one or more triggering events. The notification may be provided to a user to assist in treatment of a medical condition, such as a diabetic condition, in response to the detected triggering event associated with the event of the therapeutic protocol.
G16H 20/00 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
91.
OPTIMIZATION AND PERSONALIZATION OF THERAPEUTIC PROTOCOLS
Embodiments are described herein for optimizing and personalizing therapeutic protocols to treat a medical condition. An event of a therapeutic protocol may be determined. One or more triggering events may be detected for generating a notification associated with the event of the therapeutic protocol. The one or more triggering events may be determined to exceed a notification threshold indicating a level of confidence that a user will receive a notification transmitted in response to the one or more triggering events. The notification may be provided to a user to assist in treatment of a medical condition, such as a diabetic condition, in response to the detected triggering event associated with the event of the therapeutic protocol.
G16H 20/00 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
92.
INSERTION SYSTEM AND METHOD FOR INSERTING A MEDICAL DEVICE THECHNICAL FIELD
Insertion tool for inserting at least a part of a medical device into a subject, insertion device comprising the insertion tool and an insertion mechanism, and method for manufac- turing the insertion tool, wherein the insertion tool comprises a penetrating portion that com- prises a composite material comprising at least one first material and at least one second material, wherein the first material is an amorphous material or amorphous composite, the second material is a fibrillary material or fibrillary composite or a crystalline material or crystalline composite, a fluid absorption of the first material of the composite material is higher than a fluid absorption of the second material of the composite material, and the insertion device is adapted to soften when in contact with a body fluid at least due to the fluid absorption of the amorphous material or amorphous composite.
A61L 31/12 - Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material
A61L 31/14 - Materials characterised by their function or physical properties
A61M 5/32 - NeedlesDetails of needles pertaining to their connection with syringe or hubAccessories for bringing the needle into, or holding the needle on, the bodyDevices for protection of needles
A61M 25/06 - Body-piercing guide needles or the like
A61M 37/00 - Other apparatus for introducing media into the bodyPercutany, i.e. introducing medicines into the body by diffusion through the skin
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
93.
Display screen with graphical user interface for glucose management
A method for determining analyte concentration in a body fluid using a mobile device having a camera and a lidar sensor that have an overlapping field of view. In the method, an object is selected and the user is prompted to apply a body fluid sample to a reagent test region. The user is prompted to provide the object within the overlapping field of view of the camera and the lidar sensor. The processor of the mobile device generates a lidar measurement data set representing the object, which is compared to a pre-generated data set. When there is a degree of congruence from the comparison that is above a pre-determined minimum, the camera captures an image of the reagent test region having the body fluid sample applied thereto and concentration of analyte in the sample is determined. When the congruence is below a pre-determined minimum, image capturing is not allowed.
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
G01N 21/77 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
G01N 33/52 - Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper
G01S 17/88 - Lidar systems, specially adapted for specific applications
An analyte sensor (110) for determining at least one analyte and a method (140) for producing an analyte sensor (110) are disclosed. The analyte sensor (110) comprises:
a substrate (112);
a working electrode (118) and a conductive layer (124) located on different sites on the substrate (112);
a silver comprising layer (126) partially covering the conductive layer (124); and
a protective layer (128), which
comprises at least one electrically conductive material; and
covers the silver comprising layer (126) apart from at least one at least one hole that provides access for at least one body fluid comprising the at least one analyte to the silver comprising layer (126).
An analyte sensor (110) for determining at least one analyte and a method (140) for producing an analyte sensor (110) are disclosed. The analyte sensor (110) comprises:
a substrate (112);
a working electrode (118) and a conductive layer (124) located on different sites on the substrate (112);
a silver comprising layer (126) partially covering the conductive layer (124); and
a protective layer (128), which
comprises at least one electrically conductive material; and
covers the silver comprising layer (126) apart from at least one at least one hole that provides access for at least one body fluid comprising the at least one analyte to the silver comprising layer (126).
Although the analyte sensor (110) as disclosed herein has a reduced overall size, sufficient space is, nevertheless, provided for the silver comprising layer (126) coated by the protective layer (128) while, concurrently, further sufficient space remains which is neither coated by the silver comprising layer (126) nor by the protective layer (128).
An analyte sensor (110) for determining at least one analyte and a method (140) for producing an analyte sensor (110) are disclosed. The analyte sensor (110) comprises:
a substrate (112);
a working electrode (118) and a conductive layer (124) located on different sites on the substrate (112);
a silver comprising layer (126) partially covering the conductive layer (124); and
a protective layer (128), which
comprises at least one electrically conductive material; and
covers the silver comprising layer (126) apart from at least one at least one hole that provides access for at least one body fluid comprising the at least one analyte to the silver comprising layer (126).
Although the analyte sensor (110) as disclosed herein has a reduced overall size, sufficient space is, nevertheless, provided for the silver comprising layer (126) coated by the protective layer (128) while, concurrently, further sufficient space remains which is neither coated by the silver comprising layer (126) nor by the protective layer (128).
(FIG. 1)
Systems and methods for measuring an analyte include devices configured to perform an analyte testing operation. The devices include a wearable electronic device and a remote device operatively connected to each other and each having a processor, the processors cooperating with each other in the execution of program instructions to measure an analyte. The wearable electronic device includes a camera configured to generate a video stream, which is analyzed to identify missing test components, to identify the application of a body fluid on a test strip where the sample undergoes changes in one or more optical properties, the image of which is analyzed to determine a level of the analyte. The wearable electronic device further includes a head-up display (HUD) for providing output messages to the user relating to the performance and status of the analyte testing operation.
G06V 20/40 - ScenesScene-specific elements in video content
G01N 21/78 - Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
G01N 33/52 - Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper
The present invention relates to an analyte sensor comprising a substrate, a first conductive material, a second conductive material, a first layer and a second layer, wherein the first and the second layer, independently of one another have a varying thickness along the length of the substrate and/or are located on the substrate as at least two fields separate from one another. The present invention furthermore relates to a method for manufacturing the analyte sensor and an analyte sensor system comprising the analyte sensor.
Systems and methods for measuring an analyte include devices configured to perform an analyte testing operation. The devices include a wearable electronic device and a remote device operatively connected to each other and each having a processor, the processors cooperating with each other in the execution of program instructions configured to direct the devices in the performance of the analyte testing operation. The wearable electronic device includes a camera configured to generate a video stream and one or more images relating to a user removing a test strip from a vial, producing a bodily fluid sample, and applying the sample to a deposit site of the test strip where the sample undergoes changes in one or more optical properties, the image of which is analyzed to determine a level of the analyte. The wearable electronic device further includes a head-up display (HUD) for providing output messages to the user relating to the performance and status of the analyte testing operation.
A61B 5/1455 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using optical sensors, e.g. spectral photometrical oximeters
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 90/92 - Identification means for patients or instruments, e.g. tags coded with colour
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
99.
METHOD AND SYSTEM FOR IMPROVED OPTICAL ANALYTE MEASUREMENTS
A method for measuring an analyte includes identifying a test strip in a video stream generated by a camera based on at least one registration mark associated with the test strip depicted in the video stream, identifying application of a fluid dose to a deposit site formed on the test strip based on the video stream, activating a timer in response to the identification of the application of the fluid dose, generating at least one optical measurement of a reagent located at a measurement site on the test strip, and generating a measurement of an analyte in the fluid dose based on the at least one optical measurement of the reagent only in response to the at least one optical measurement being generated after a predetermined minimum time period has elapsed and prior to a predetermined maximum time period elapsing subsequent to the activating of the timer.
A61B 5/1455 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using optical sensors, e.g. spectral photometrical oximeters
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/103 - Measuring devices for testing the shape, pattern, size or movement of the body or parts thereof, for diagnostic purposes
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G06V 20/40 - ScenesScene-specific elements in video content
G06V 40/20 - Movements or behaviour, e.g. gesture recognition
The present invention relates to a manual insertion aid for inserting a cannula unit into a cannula holder. The manual insertion aid comprises a handle and two jaws projecting from the handle and forming a receiving opening that is configured for engaging with a cannula unit. In order to provide a simple and lightweight insertion aid, the minimum clearance between the two jaws is greater than or equal to 1.5 mm and smaller than or equal to 7 mm, and wherein the maximum projecting length of each of the two jaws from the handle is greater than or equal to 4 mm and smaller than or equal to 18 mm.
patents
